These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11714778)

  • 1. Tolerance or immunity to a tumor antigen expressed in somatic cells can be determined by systemic proinflammatory signals at the time of first antigen exposure.
    Frazer IH; De Kluyver R; Leggatt GR; Guo HY; Dunn L; White O; Harris C; Liem A; Lambert P
    J Immunol; 2001 Dec; 167(11):6180-7. PubMed ID: 11714778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors.
    Matsumoto K; Leggatt GR; Zhong J; Liu X; de Kluyver RL; Peters T; Fernando GJ; Liem A; Lambert PF; Frazer IH
    J Natl Cancer Inst; 2004 Nov; 96(21):1611-9. PubMed ID: 15523090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal.
    Dunn LA; Evander M; Tindle RW; Bulloch AL; de Kluyver RL; Fernando GJ; Lambert PF; Frazer IH
    Virology; 1997 Aug; 235(1):94-103. PubMed ID: 9300040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes.
    Frazer IH; Fernando GJ; Fowler N; Leggatt GR; Lambert PF; Liem A; Malcolm K; Tindle RW
    Eur J Immunol; 1998 Sep; 28(9):2791-800. PubMed ID: 9754566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
    Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
    J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide.
    Leggatt GR; Dunn LA; De Kluyver RL; Stewart T; Frazer IH
    Immunol Cell Biol; 2002 Oct; 80(5):415-24. PubMed ID: 12225377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1 signalling determines the fate of skin grafts expressing non-self protein in keratinocytes.
    Hadis U; Leggatt GR; Thomas R; Frazer IH; Kovacs EM
    Exp Dermatol; 2010 Aug; 19(8):723-9. PubMed ID: 20545758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human growth hormone presented by K14hGH-transgenic skin grafts induces a strong immune response but no graft rejection.
    Zhong J; Matsumoto K; De Kluyver R; Fernando GJ; Leggatt GR; Frazer IH
    Immunol Cell Biol; 2004 Dec; 82(6):577-86. PubMed ID: 15550115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization and immunotherapy for cancers involving infection by a human papillomavirus in a mouse model.
    Li J; Sun Y; Garen A
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16232-6. PubMed ID: 12446839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of Antigen Presenting Cells to Skin Draining Lymph Node From HPV16E7-Expressing Skin Requires E7-Rb Interaction.
    Kuo P; Teoh SM; Tuong ZK; Leggatt GR; Mattarollo SR; Frazer IH
    Front Immunol; 2018; 9():2896. PubMed ID: 30619266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein.
    Herd K; Fernando GJ; Dunn LA; Frazer IH; Lambert P; Tindle RW
    Virology; 1997 Apr; 231(1):155-65. PubMed ID: 9143315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model.
    Fernando GJ; Stewart TJ; Tindle RW; Frazer IH
    J Immunol; 1998 Sep; 161(5):2421-7. PubMed ID: 9725239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR7 stimulation augments T effector-mediated rejection of skin expressing neo-self antigen in keratinocytes.
    Zhong J; Hadis U; De Kluyver R; Leggatt GR; Fernando GJ; Frazer IH
    Eur J Immunol; 2008 Jan; 38(1):73-81. PubMed ID: 18157820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site.
    Lamikanra A; Pan ZK; Isaacs SN; Wu TC; Paterson Y
    J Virol; 2001 Oct; 75(20):9654-64. PubMed ID: 11559797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant NKT cells in hyperplastic skin induce a local immune suppressive environment by IFN-gamma production.
    Mattarollo SR; Rahimpour A; Choyce A; Godfrey DI; Leggatt GR; Frazer IH
    J Immunol; 2010 Feb; 184(3):1242-50. PubMed ID: 20028654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes.
    Doan T; Chambers M; Street M; Fernando GJ; Herd K; Lambert P; Tindle R
    Virology; 1998 May; 244(2):352-64. PubMed ID: 9601506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing time-, ignorance-, and danger-based models of tolerance.
    Anderson CC; Carroll JM; Gallucci S; Ridge JP; Cheever AW; Matzinger P
    J Immunol; 2001 Mar; 166(6):3663-71. PubMed ID: 11238605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Natural" presentation of human papillomavirus type-16 E7 protein to immunocompetent mice results in antigen-specific sensitization or sustained unresponsiveness.
    Chambers MA; Wei Z; Coleman N; Nash AA; Stanley MA
    Eur J Immunol; 1994 Mar; 24(3):738-45. PubMed ID: 8125141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.
    Chu NR; Wu HB; Wu T; Boux LJ; Siegel MI; Mizzen LA
    Clin Exp Immunol; 2000 Aug; 121(2):216-25. PubMed ID: 10931134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor sensitivity to IFN-gamma is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors.
    Dominiecki ME; Beatty GL; Pan ZK; Neeson P; Paterson Y
    Cancer Immunol Immunother; 2005 May; 54(5):477-88. PubMed ID: 15750832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.